Core Insights - Amer Sports, Inc. reported quarterly earnings of $0.06 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, and showing an increase from $0.05 per share a year ago, resulting in an earnings surprise of +200.00% [1] - The company achieved revenues of $1.24 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.22% and increasing from $993.8 million year-over-year [2] - Amer Sports shares have increased approximately 34.1% since the beginning of the year, significantly outperforming the S&P 500's gain of 9.7% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.21 on revenues of $1.55 billion, and for the current fiscal year, it is $0.77 on revenues of $6.08 billion [7] - The estimate revisions trend for Amer Sports was favorable prior to the earnings release, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Leisure and Recreation Products industry, to which Amer Sports belongs, is currently ranked in the bottom 29% of over 250 Zacks industries, suggesting potential challenges in overall industry performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Company Performance - KORE Group Holdings, Inc. reported a quarterly loss of $0.5 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.47, and an improvement from a loss of $0.99 per share a year ago, indicating a year-over-year improvement [1] - Cerberus Telecom Acquisition posted revenues of $71.25 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.35% and showing an increase from year-ago revenues of $67.87 million [2] - Cerberus Telecom Acquisition has surpassed consensus revenue estimates three times over the last four quarters [2] Stock Performance - Cerberus Telecom Acquisition shares have declined approximately 26.1% since the beginning of the year, contrasting with the S&P 500's gain of 10% [3] - The current consensus EPS estimate for Cerberus Telecom Acquisition is -$0.33 on $75.1 million in revenues for the coming quarter and -$1.76 on $293.55 million in revenues for the current fiscal year [7] Industry Outlook - The Zacks Industry Rank for Internet - Software is currently in the top 30% of over 250 Zacks industries, suggesting that companies in the top 50% of Zacks-ranked industries outperform those in the bottom 50% by more than 2 to 1 [8] - VNET Group, another company in the same industry, is expected to report quarterly earnings of $0.02 per share, reflecting a year-over-year change of -66.7%, with revenues expected to be $321.33 million, up 17.1% from the year-ago quarter [9][10]

Core Viewpoint - Bridgeline Digital, Inc. reported a quarterly loss of $0.07 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.05, marking a significant earnings surprise of -40.00% [1] Financial Performance - The company posted revenues of $3.85 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.64% and down from $3.94 million a year ago [2] - Over the last four quarters, Bridgeline Digital has surpassed consensus EPS estimates only once [2] Stock Performance - Since the beginning of the year, Bridgeline Digital shares have lost approximately 2.5%, contrasting with the S&P 500's gain of 10% [3] - The current Zacks Rank for the stock is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.05 on revenues of $3.94 million, and for the current fiscal year, it is -$0.25 on revenues of $15.51 million [7] - The trend of estimate revisions for Bridgeline Digital was mixed ahead of the earnings release, which could change following the recent report [6] Industry Context - The Internet - Services industry, to which Bridgeline Digital belongs, is currently ranked in the top 40% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Company Performance - Exro Technologies Inc. reported a quarterly loss of $0.03 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.02, representing an earnings surprise of -50.00% [1] - The company posted revenues of $2.1 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 57.78%, and a decline from $3.85 million in the same quarter last year [2] - Over the last four quarters, Exro Technologies has not surpassed consensus EPS estimates and has topped revenue estimates only once [2] Stock Performance - Exro Technologies shares have declined approximately 40.2% since the beginning of the year, contrasting with a 10% gain in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $5.98 million, and for the current fiscal year, it is -$0.09 on revenues of $20.45 million [7] Industry Outlook - The Zacks Industry Rank for Electronics - Miscellaneous Products, which includes Exro Technologies, is currently in the bottom 33% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Exro's stock performance [5]

分组1 - Flexible Solutions International Inc. (FSI) reported quarterly earnings of $0.15 per share, exceeding the Zacks Consensus Estimate of $0.06 per share, and showing an increase from $0.1 per share a year ago, resulting in an earnings surprise of +150.00% [1] - The company posted revenues of $11.37 million for the quarter ended June 2025, which was a 2.09% miss compared to the Zacks Consensus Estimate, and an increase from $10.53 million year-over-year [2] - The stock has gained approximately 108% since the beginning of the year, significantly outperforming the S&P 500's gain of 10% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.05 on revenues of $11.57 million, and for the current fiscal year, it is $0.22 on revenues of $47.42 million [7] - The Zacks Industry Rank indicates that the Chemical - Specialty industry is currently in the bottom 30% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8]

Company Performance - Digi Power X Inc. reported a quarterly loss of $0.28 per share, which was better than the Zacks Consensus Estimate of a loss of $0.35, representing an earnings surprise of +20.00% [1] - The company posted revenues of $8.11 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.99%, although this was a decline from year-ago revenues of $9.23 million [2] - Over the last four quarters, Digi Power X has surpassed consensus EPS estimates three times [2] Stock Movement and Outlook - Digi Power X shares have increased approximately 74% since the beginning of the year, significantly outperforming the S&P 500's gain of 10% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the sustainability of the recent price movement [3][4] - The current consensus EPS estimate for the upcoming quarter is -$0.41 on revenues of $7.8 million, and for the current fiscal year, it is -$1.60 on revenues of $33.7 million [7] Industry Context - The Technology Services industry, to which Digi Power X belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Digi Power X's stock performance [5][6]

Company Performance - Actelis Networks, Inc. reported a quarterly loss of $0.21 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.16, and a decline from earnings of $0.01 per share a year ago, indicating an earnings surprise of -31.25% [1] - The company posted revenues of $0.94 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 5.9%, and a significant drop from year-ago revenues of $3.43 million [2] - Over the last four quarters, Actelis Networks has surpassed consensus EPS estimates only once and has not beaten consensus revenue estimates during the same period [2] Stock Performance - Actelis Networks shares have declined approximately 53.1% since the beginning of the year, contrasting with the S&P 500's gain of 10% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $3 million, and for the current fiscal year, it is -$0.44 on revenues of $7.52 million [7] Industry Outlook - The Communication - Components industry, to which Actelis Networks belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, suggesting a challenging environment for stock performance [8] - The performance of Actelis Networks may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8]

分组1 - Fortress Biotech reported a quarterly loss of $0.46 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.31, representing an earnings surprise of -48.39% [1] - The company posted revenues of $16.41 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 13.66%, compared to $14.9 million in the same quarter last year [2] - Fortress Biotech has surpassed consensus revenue estimates two times over the last four quarters [2] 分组2 - The stock has underperformed the market, losing about 4.7% since the beginning of the year, while the S&P 500 gained 10% [3] - The current consensus EPS estimate for the coming quarter is -$0.24 on revenues of $19.88 million, and for the current fiscal year, it is -$1.29 on revenues of $103.09 million [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is currently in the bottom 41% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Company Performance - ESS Tech, Inc. reported a quarterly loss of $0.9 per share, slightly worse than the Zacks Consensus Estimate of a loss of $0.88, but an improvement from a loss of $1.8 per share a year ago, indicating a year-over-year improvement [1] - The company posted revenues of $2.36 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.75%, but showing significant growth from $0.35 million in the same quarter last year [2] - Over the last four quarters, ESS Tech has surpassed consensus EPS estimates two times, but has not been able to beat consensus revenue estimates [2] Stock Performance - ESS Tech shares have declined approximately 71.3% since the beginning of the year, contrasting with the S&P 500's gain of 10% [3] - The company's earnings outlook and management's commentary on the earnings call will be crucial for the stock's immediate price movement [3][4] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is -$0.65 on revenues of $1.3 million, and for the current fiscal year, it is -$3.56 on revenues of $6 million [7] - Ahead of the earnings release, the estimate revisions trend for ESS Tech was favorable, resulting in a Zacks Rank 2 (Buy) for the stock, suggesting it is expected to outperform the market in the near future [6] Industry Outlook - The Electronics - Miscellaneous Products industry, to which ESS Tech belongs, is currently ranked in the bottom 33% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Company Performance - Plus Therapeutics reported a quarterly loss of $0.01 per share, outperforming the Zacks Consensus Estimate of a loss of $0.09, and showing improvement from a loss of $0.71 per share a year ago, resulting in an earnings surprise of +88.89% [1] - The company posted revenues of $1.39 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 18.24%, but showing an increase from year-ago revenues of $1.28 million [2] - Over the last four quarters, Plus has surpassed consensus EPS estimates only once and has topped consensus revenue estimates just once [2] Stock Performance - Plus shares have declined approximately 50.1% since the beginning of the year, contrasting with the S&P 500's gain of 10% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.08 on revenues of $2.21 million, and for the current fiscal year, it is -$0.55 on revenues of $7.16 million [7] Industry Outlook - The Medical - Drugs industry, to which Plus belongs, is currently ranked in the top 35% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]